Editor's Note The Joint Commission announced on December 21 that they are eliminating 168 standards (14%) and revising 14 other standards across its accreditation programs in the new year. The Joint Commission additionally announced that it will not raise accreditation fees for domestic hospitals in the coming year due the…
Editor's Note The Food and Drug Administration (FDA) on November 29 posted Exela Pharma Sciences’ expansion of its recall of Sodium Bicarbonate Injection, USP, 8.4%, 50 mEq/50 mL vial, 20-count carton. The product poses a safety concern because of vial breakage with flying glass when pressurized while preparing the product for…
Editor's Note A federal judge in Louisiana declined a case brought by 14 states that challenged the Biden administration’s mandate requiring COVID-19 vaccination for eligible staff at healthcare facilities participating in Medicare and Medicaid Programs, the December 8 Becker’s Hospital Review reports. The states have 60 days to appeal the…
Editor's Note The Joint Commission announced on December 7 that it was recognized by the Department of Health and Human Services at the 2022 United Nations Climate Change Conference for its actions to decarbonize the healthcare sector and make healthcare facilities more resilient to climate change. The Joint Commission formally…
Editor's Note The Centers for Medicare & Medicaid Services (CMS) released a new memorandum on November 28 emphasizing the importance of enforcing regulations and expectations to create a safe environment for hospital staff when delivering patient care, the American Hospital Association reported on November 28. According to the memo, the…
Editor's Note The Food and Drug Administration, on November 23, identified the recall by Baxter Hillrom of its WatchCare Incontinence Management System (IMS) as Class I, the most serious. The recall was initiated because of the risk for radiofrequency (RF) emissions from WatchCare devices that may interfere with other devices,…
Editor's Note The Food and Drug Administration (FDA) on November 16 identified the recall by Insulet of its Omnipod DASH Insulin Management System Personal Diabetes Manager (PDM) as Class I, the most serious. The recall was initiated because of PDM battery issues, including: Battery swelling Fluid leakage from the battery…
On September 15, 2022, AORN released its updated Guideline for Processing Flexible Endoscopes. Over the past several years, there has been significant research on flexible endoscope processing—research that met the stringent requirements and has been included in this revised guideline by AORN’s lead author and team. Endoscope processing begins with…
Editor's Note The Centers for Medicare and Medicaid Services (CMS) on November 10 issued a report outlining its plans, “for the first time,” to improve the transparency, accountability, and completeness of health equity data across its programs. “CMS defines health equity data as the combination of quantitative and qualitative elements…
Editor's Note The Centers for Medicare & Medicaid Services (CMS), through the Hospital Readmissions Reduction Program, evaluated more than 2 years of readmission cases for Medicare patients and penalized 2,273 hospitals, Kaiser Health News November 1 reports. This is the lowest number of penalties since 2014. The Hospital Readmissions Reduction…